Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 55,000 shares at $32.06 ($1.7M) on 2020-09-01, disclosed to the SEC on 2020-09-03.
Open-market sale of $1.7M HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.29 | 14,090 | $441K | 25.3% |
| 2 | $31.29 | 14,090 | $441K | 25.3% |
| 3 | $32.06 | 13,410 | $430K | 24.7% |
| 4 | $32.06 | 13,410 | $430K | 24.7% |
| Total | $31.67 avg | 55,000 | $1.7M | 100% |
| Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |
| HCAT | SELL | 2020-04-03 | $1.4M | — | Filing → |